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Phosphorylation f a 38 kDa protein (~38) present in rat liver plasma membrane has been shown for the 
first time to be enhanced by ras proteins. This increase in phosphorylation is about 3-16-fold depending 
on the incubation time and the type of ras protein used. Acid treatment removes phosphate from this protein 
suggesting that the phosphorylation i volves phosphoramidate d rivatives of basic amino acids. Experi- 
ments carried out in the presence of diethylpyrocarbonate suggest that the phosphorylation ccurs on (a) 
histidine residue(s). It is probable that the function of p38 in the cell is modulated by ras proteins through 
phosphorylation. The significance of phosphorylation f p38 in terms of malignant transformation is pre- 
sently unknown. 
38 kDa protein; ras protein; Phosphorylation; (Rat liver plasma membrane) 
1. INTRODUCTION 
The oncogenes belonging to the ras family code 
for proteins of M, - 21000 (~21) [l-3]. The precise 
biochemical function of these proteins in the cell 
and their role in malignant ransformation are not 
yet fully understood. But they are known to bind 
GTP and GDP and have GTPase activity [4-61. 
Recently there have been reports of the involve- 
ment of these proteins in the modulation of 
phosphorylation of certain mitochondrial mem- 
brane proteins [7,8]. Evidence gathered by sub- 
cellular fractionation and electron microscopy has 
shown that both normal and transforming ras pro- 
teins are present at the inner surface of the plasma 
membrane [9,10]. If ras proteins have (a) biol- 
ogical function(s) in addition to, or apart from 
their GTP-binding properties and consequential 
role in signal transduction initiated by this me- 
chanism, the target proteins are likely to be in the 
Correspondence address: A.N. Hegde, Centre for 
Cellular & Molecular Biology, Uppal Road, Hyderabad 
500 007, India 
plasma membrane, the natural location of the p21 
proteins. Since phosphorylation is one of the most 
common post-translational modifications by 
which the functions of proteins are modulated, we 
sought to check if ras proteins affect the phos- 
phorylation of any plasma membrane proteins. In 
this communication we report for the first time 
evidence for enhancement in phosphorylation of a 
38 kDa protein present in rat liver plasma mem- 
brane by p21 ras proteins. 
2. MATERIALS AND METHODS 
The ras proteins RASl[ll], EC[12], EC/v- 
Ha[12] and EJ/v-Ha[l2] expressed in Escherichia 
coli and purified to homogeneity were provided by 
M. Poe, R.B. Stein and J.B. Gibbs of Merck Sharp 
and Dohme Research Laboratories. 
Plasma membranes were isolated from livers of 
male Wistar rats according to Lesko et al. [13]. 
The mitochondrial fraction was obtained from rat 
liver as described by Greenawalt [14] and was fur- 
ther purified by the procedure of Bogenhagen and 
Clayton [ 151. Solubilization by glucose 6-phos- 
phate and phosphorylation of proteins from mito- 
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chondria were carried out as reported by Backer 
and Weinstein [B]. 
The phosphorylation reactions which contained 
rat liver plasma membrane proteins were perform- 
ed at room temperature in a 100 ~1 reaction mix- 
ture comprising 1 mM Hepes at pH 7.5, 0.21 M 
D-mannitol, 0.07 M sucrose, 2.5 mM MgClz and 
20 pg liver plasma membrane proteins with or 
without ras protein (at different concentrations as 
shown in results) or GDP at various concentrations 
(50-2500 nM) as required for individual ex- 
periments. The reactions were started by adding 10 
&i [T-~~P] ATP (3000 Ci/mmol) and were ter- 
minated with the addition of 50 ~1 sample buffer 
(to give final concentrations of 0.0625 M Tris, pH 
6.8, 2% SDS, 10% glycerol, 5% 2-mercapto- 
ethanol and 0.001% Bromophenol blue). The 
samples were then boiled at 100°C for 5 min and 
analyzed by discontinuous SDS gel electrophoresis 
[16] with 10% acrylamide in the resolving gel. The 
gels were fixed in a solution containing 10% 
isopropyl alcohol and 10 mM sodium pyrophos- 
phate, washed several times with the same solu- 
tion, dried and autoradiographed. In order to 
determine the lability of the phosphate moieties, 
gels were treated overnight with a solution con- 
taining 15% (v/v) acetic acid and 15% (v/v) 
methanol. Staining and destaining of the gels were 
accomplished uring the same period by including 
0.2% Coomassie blue in the solution described 
above for the first 2 h. The relative intensities of 
the bands on the autoradiograms were measured 
by using a soft laser scanning densitometer (Biom- 
ed Instruments, CA). 
The proteins were transferred from gels to 
nitrocellulose paper according to the method 
described by Towbin et al. [17] and the blots were 
probed with antibodies using the procedure de- 
scribed by Gould et al. [18] with minor modifica- 
tions. 
3. RESULTS 
The phosphorylation of rat liver plasma mem- 
brane was carried out in the presence of four ras 
proteins viz., RASl (The 21 kDa protein encoded 
by the ras oncogene of Harvey murine sarcoma 
virus with Arg-12, Thr-59 and Gln-61) [ll], EC 
(normal human c-Ha-ras-1 with Gly-12, Ala-59 
and Gln-61) [12], EC/v-Ha (EC containing 3 ’ 
ras proteins 
Fig. 1. Extent of enhancement in phosphorylation of p38 
by rus proteins. Control value is taken as unity. The 
phosphorylation reactions were performed for 5 min or 
15 min. (Columns: C, Control; 1, RASl; 2, EC; 3, 
EC/v-Ha; 4, EJ/v-Ha. 
Fig.2. Extent of enhancement in phosphorylation of p38 
with increasing concentrations of p21 r-us. Liver plasma 
membranes (20pg) were incubated with various concen- 
trations of EC (lo+” M to 2.5 x 10e6 M) and the phos- 
phorylation reactions were performed as described in 
section 2. Following the autoradiography the p38 band 
was removed from the dried gel and counted for radio- 
activity. Values are expressed relative to control. 
Control value is taken as unity. 
75 
Volume 217, number 1 FEBS LETTERS June 1987 
Fig.3. Enhancement in phosphorylation of 38 kDa 
protein (~38) by rus protein. Phosphorylation reactions 
were carried out for 5 min as described in section 2. 
Lanes: 1, liver plasma membrane, control; 2, liver 
plasma membrane with RASl. 
coding region of viral Harvey ras with Gly-12, 
Thr-59 and Gln-61) [12], and EJ/v-Ha (on- 
cogenically activated human c-Ha-ras-1 containing 
3 ’ coding region of viral Harvey T(IS with Val-12, 
Thr-59 and Gln-61) [12]. With all the rus variants 
tested, a large increase in phosphorylation of a 38 
kDa protein (~38) was observed (figs 1 and 3). 
When the reaction mixture was incubated for 5 
min, this increase was 8-16-fold and with 15 min 
incubation time the increase was 3-4-fold over 
control (fig.1). Further, enhancement in 
phosphorylation of p38 was tested at various con- 
centrations of EC (10 pM-2500 nM). Even at the 
lowest concentration of ras there was slight 
enhancement in phosphorylation of p38 (fig.2). 
In order to check the nature of phosphorylation 
the gels were treated with acid prior to 
autoradiography (see section 2). It was observed 
that almost all of the 32P incorporated into p38 was 
removed by acid treatment (fig.4). This suggested 
that the phosphorylation occurred on one or more 
of the basic amino acids such as arginine, histidine 
and lysine. Furthermore, when the phosphoryla- 
tion was carried out in the presence of 10 mM 
diethylpyrocarbonate (DEP) the phosphorylation 
of p38 was completely inhibited in the control sam- 
ple as well as in samples with RASl , EC, EV/v-Ha 
and GDP (500 nM-2500 nM) suggesting the possi- 
ble site(s) of phosphorylation to be (a) histidine 
residue(s) (fig.5). 
All the four variants of ras used in our study are 
1: 1 binary GDP complexes [19]. GDP binds to 
these proteins with a dissociation constant of 
about IO* M-’ [20]. The expected dissociation of 
bound GDP at the concentration of rus proteins 
used in our experiments (micromolar) would be 
5-20%. In order to check whether GDP alone had 
any effect on the phosphorylation of ~38, 
phosphorylation reactions were carried out using 
different concentrations of GDP. The range of 
concentrations covered the levels of free GDP ex- 
pected and the total GDP associated with the ras 
proteins. It was observed that GDP also enhanced 
the phosphorylation of p38 (table 1). The increase 
at 5 min incubation was higher than that observed 
at 15 min at all the different concentrations of 
GDP just as with the ras proteins. But there were 
clear-cut quantitative differences in the 
enhancements observed with GDP (from 50-2500 
nM) and ras proteins. The increase in phosphoryla- 
Table 1 
Effect of GDP on the phosphorylation of p38 
Concentration Extent of enhancement in phos- 
of GDP phorylation of ~38 (olo of control) 
(nW 5 mina 15 mina 
0 100 100 
50 186 101 
100 238 102 
500 397 143 
1000 438 175 
2000 463 199 
2500 524 204 
a Phosphorylation reactions were performed as 
described in section 2 for 5 min or 15 min as stated 
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p38- 
Fig.4. Effect of acid treatment on phosphorylation of ~38. Phosphorylation reaction mixtures were incubated for 15 
min and the gels were autoradiographed with(B) or without (A) acid treatment. Lanes: 1, control; 2, RASl; 3, EC/v- 
Ha; 4, EC; 5, EJ/v-Ha. 
tion of p38 with ras protein was at least 2-fold 
higher than the increase brought about by the 
highest possible concentration of GDP expected to 
be present in association with the ras proteins. 
In order to ascertain whether the phosphoryla- 
tion of p38 that we have observed in liver plasma 
membrane is distinct from the phosphorylated pro- 
teins of the mitochondria reported by Backer and 
Weinstein [B], a comparison between the effect of 
ras proteins on the phosphorylation of liver plasma 
membrane proteins and mitochondrial membrane 
proteins was made under identical conditions. 
These results are presented in fig.6. Our results 
confirm the observations of Backer and Weinstein 
in demonstrating increased phosphorylation of a 
36 kDa protein in mitochondrial membranes. But, 
in addition, it can be clearly seen that in the plasma 
membrane preparations from liver tissues the pro- 
tein that shows increased phosphorylation in the 
presence of ras proteins is distinct in molecular 
mass (38 kDa) from the one (36 kDa) reported by 
Backer and Weinstein. These authors have also 
reported that ras proteins inhibit the phosphoryla- 
tion of a 17 kDa protein in mitochondrial mem- 
branes. However, with plasma membrane proteins 
r-as proteins did not bring about any changes in the 
extent of phosphorylation of any protein other 
than ~38. 
In order to check whether the p38 is different 
from or similar to the transformation associated 
34-39 kDa (~36) protein reported in various 
systems [18] Western blot experiments were done 
with anti-p36 antibodies raised against ~36, the 
substrate of pp60src from chicken embryo 
fibroblasts (kindly provided by Dr G.S. Martin, 
University of California) and antiserum raised 
against p36 from Zajdela ascitic hepatoma (a 
chemically induced rat liver tumour). Neither of 
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these antibodies cross-reacted with p38 from liver 
plasma membrane (not shown). 
4. DISCUSSION 
We have demonstrated that ras proteins enhance 
the phosphorylation of a 38 kDa protein in rat liver 
plasma membrane (~38). We have also shown that 
this protein is distinct from the p36 reported to be 
present in the plasma membranes of various 
tumours and normal tissues [18]. Further, we have 
established that the ~38 from liver plasma mem- 
brane is different from the mitochondrial mem- 
brane protein (36 kDa) whose phosphorylation has 
been reported to be increased by ras proteins [7,8]. 
The enhancements in phosphorylation of ~38 
observed at 5 min incubation with all the four ras 
variants are higher compared to those observed at 
15 min incubation time. A similar decrease in 
phosphorylation of p38 at 15 min as against 5 min 
incubation was seen with GDP also. Qualitatively 
similar observations were made by Backer and 
Weinstein [8] in the case of phosphorylation of a 
mitochondrial membrane protein. It is likely that 
in both cases the observed reduction in phosphor- 
ylation with time could be resulting from probable 
protein phosphatase activity present in the mem- 
brane preparations. 
The experiments with various concentrations of 
EC showed that the ras protein is effective in 
Fig.5. Diethylpyrocarbonate (DEP) inhibits phosphor- 
ylation of ~38. Phosphorylation reactions were carried 
out for 5 min as described in section 2 with or without 
10 mM DEP. Lanes: 1, liver plasma membrane, control; 
2, liver plasma membrane with DEP; 3, liver plasma 
membrane, with RASl, control; 4, liver plasma mem- 
Fig.6. Comparison of phosphorylation patterns of rat 
liver plasma membrane proteins with that of mito- 
chondrial membrane proteins. Lanes: 1, liver plasma 
membrane, control; 2, liver plasma membrane with 
RASl; 3, mitochondrial membrane proteins, control; 4, 
mitochondrial membrane proteins with RASI; 5, mito- 
chondrial membrane proteins with RASl treated with 
acid prior to autoradiography. The positions of ~38 
from liver plasma membrane and 36 kDa protein from 
brane with RASl and DEP. mitochondrial membrane are indicated. 
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bringing about the enhancement in phosphoryla- 
tion of ~38 even at the lowest concentration tested 
(nearly 2-fold over control at 10 pM level). The 
present experiments were performed keeping the 
membrane protein concentration constant (20 pug). 
It may also be noted that the concentrations of p2 1 
ras required to bring about increased phosphoryla- 
tion of ~38 could be different in vivo and it would 
be important to check whether even smaller con- 
centrations of p21 could bring about increased 
phosphorylation of ~38 under these conditions. 
transformation-related events. It is also necessary 
to see if oncogenically activated rus proteins act 
differently on phosphorylation of ~38 from nor- 
mal ras proteins. So far, the ras proteins are 
known to have only autokinase activity [ 121. Since 
~38 is found in the plasma membrane where p21 is 
located, it would be important to determine the 
possible function of ~38 and check whether p21 ras 
modulates the function of ~38 by phosphorylation. 
Although GDP alone also influences the phos- 
phorylation of ~38, our results clearly show that 
the increase in phosphorylation of ~38 brought 
about by ras proteins is higher than that observed 
with GDP. GDP is associated with rus proteins as 
a complex and even if the maximum dissociation is 
taken into account, the enhancement obtained at 
this level (500 nM GDP at the ras protein concen- 
trations used in the present experiments, table 1) is 
2-4-times less than that is observed with ras pro- 
teins both at 5 min and 15 min incubation times. 
Also, even the total GDP present in association 
with the ras protein cannot bring about the same 
extent of enhancement observed with rus proteins. 
Our results clearly indicate that at concentrations 
of GDP in excess of the total GDP expected to be 
associated with rus proteins, the enhancement in 
phosphorylation of ~38 is considerably lower than 
that observed with ras proteins (see table 1). 
The acid lability of the phosphate incorporated 
into ~38 would argue that the phosphorylation in- 
volved phosphoramidates and occurred on basic 
amino acids such as arginine, histidine and lysine. 
When the reactions were carried out in the pre- 
sence of 10 mM diethylpyrocarbonate, the phos- 
phorylation of ~38 was completely inhibited (fig. 
5). As DEP is a specific inhibitor of histidine 
phosphorylation [21] our results narrow down the 
observed phosphorylation of ~38 to (a) histidine 
residue(s). The significance of such a phosphoryla- 
tion is not clear, although protein kinases that 
phosphorylate structural proteins on basic amino 
acids are known [22]. 
Our present observations assume significance in 
terms of understanding ras function in the light of 
several other observations, despite the fact that we 
do not know at present the biological significance 
of the ~38 phosphorylation. The work of Finkel et 
al. [23], Lacal et al. [24] and Der et al. [25] suggest 
that activation of efficient transforming properties 
by ras p21 proteins can occur by mechanisms in- 
dependent of variation in GTP binding or GTPase 
activity. Furthermore, the work of McCormick et 
al. [26] suggests that the amino acids defining 
guanine specificity are Asn-116 and Asp-l 19 and 
that sequences around amino acid 145 may also 
contribute to guanine binding. On the other hand, 
the phosphoryl-binding region is made up of 
amino acid sequences from 10 to 16 and from 57 
to 63 of ~21. In the light of these results taken 
together with the observations that mutations at 
positions 12, 59 and 61 in c-rus p21 are concerned 
with transforming properties, a situation exists 
whereby it is not possible to correlate the 
biologically significant mutation with any struc- 
tural changes at the GTP-binding region. It is, 
therefore, important to examine the biological 
significance of the ~38 phosphorylation that we 
have observed. 
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